Subcutaneous adipose tissue thickness in adults - Correlation with BMI and recommendations for pen needle lengths for subcutaneous self-injection

Clinical Endocrinology

Volumn 75, Issue 6, 2011, Pages 786-790

  Ludescher, Burkhard ^a   Rommel, Marc ^b   Willmer, Tobias ^a   Fritsche, Andreas ^a   Schick, Fritz ^a   MacHann, Juergen ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b The Development of New Drug Delivery Devices and Digital Business Models at Ypsomed   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL WALL; ADULT; ARM; ARTICLE; BODY MASS; BUTTOCK; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN EXPERIMENT; INJECTION SITE; MALE; NEEDLE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; SELF INJECTION; SEX DIFFERENCE; SUBCUTANEOUS FAT; SUBCUTANEOUS FAT THICKNESS; SUBCUTANEOUS SELF INJECTION; THIGH; WAIST HIP RATIO;

ADULT; BODY COMPOSITION; BODY MASS INDEX; COHORT STUDIES; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NEEDLES; ORGAN SIZE; PRACTICE GUIDELINES AS TOPIC; SELF ADMINISTRATION; SUBCUTANEOUS FAT; WAIST-HIP RATIO; WHOLE BODY IMAGING;

EID: 80855144842     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04132.x     Document Type: Article

References (21)

1. Stockl, K., Ory, C., Vanderplas, A., et al. (2007) An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe. Current Medical Research and Opinion, 23, 133-146. (Pubitemid 46191679)
2. Thurman, J.E., (2007) Insulin pen injection devices for management of patients with type 2 diabetes: considerations based on an endocrinologist's practical experience in the United States. Endocrine Practice, 13, 672-678.
3. Asche, C.V., McWhorter, L.S., &, Raparla, S., (2010) Health economics and compliance of vials/syringes versus pen devices: a review of the evidence. Diabetes Technology & Therapeutics, 12, S101-S108.
4. Hirsch, L.J., Gibney, M.A., Albanese, J., et al. (2010) Comparative glycemic control, safety and patient ratings for a new 4 mm x 32G insulin pen needle in adults with diabetes. Current Medical Research and Opinion, 26, 1531-1541.
5. Vaag, A., Pedersen, K.D., Lauritzen, M., et al. (1990) Intramuscular versus subcutaneous injection of unmodified insulin: consequences for blood glucose control in patients with type 1 diabetes mellitus. Diabetic Medicine, 7, 335-342. (Pubitemid 20145983)
6. Fried, A., Östman, J., &, Linde, B., (1990) Hypoglycemia risk during exercise after intramuscular injection of insulin in thigh in IDDM. Diabetes Care, 13, 473-477. (Pubitemid 20145949)
7. Tubiana-Rufi, N., Belarbi, N., Du Pasquier-Fediaevsky, L., et al. (1999) Short needles (8 mm) reduce the risk of intramuscular injections in children with type 1 diabetes. Diabetes Care, 22, 1621-1625. (Pubitemid 29458383)
8. Hildebrandt, P., (1991) Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors. Danish Medical Bulletin, 38, 337-346.
9. Hildebrandt, P., Sestoft, L., &, Nielsen, S.L., (1983) The absorption of subcutaneously injected short-acting soluble insulin: influence of injection technique and concentration. Diabetes Care, 6, 459-462. (Pubitemid 13005552)
10. Annersten, M., &, Willman, A., (2005) Performing subcutaneous injections: a literature review. Worldviews on Evidence-Based Nursing, 2, 122-130. (Pubitemid 41702683)
11. Frid, A., Hirsch, L., Gaspar, R., et al. (2010) Scientific Advisory Board for the Third Injection Technique Workshop. New injection recommendations for patients with diabetes. Diabetes & Metabolism, 36, S3-S18.
12. Gibney, M.A., Arce, C.H., Byron, K.J., et al. (2010) Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Current Medical Research and Opinion, 26, 1519-1530.
13. Thow, J., &, Home, P., (1990) Insulin injection technique. British Medical Journal, 301, 3-4. (Pubitemid 20210975)
14. Thow, J.C., Johnson, A.B., Fulcher, G., et al. (1990) Different absorption of isophane (NPH) insulin from subcutaneous and intramuscular sites suggests a need to reassess recommended insulin injection technique. Diabetic Medicine, 7, 600-602. (Pubitemid 20229736)
15. Ludescher, B., Machann, J., Eschweiler, G.W., et al. (2009) Correlation of fat distribution in whole body MRI with generally used anthropometric data. Investigative Radiology, 44, 712-719.
16. Laurent, A., Mistretta, F., Bottigioli, D., et al. (2007) Echographic measurement of skin thickness in adults by high frequency ultrasound to assess the appropriate microneedle length for intradermal delivery of vaccines. Vaccine, 25, 6423-6430. (Pubitemid 47096751)
17. Machann, J., Thamer, C., Schnoedt, B., et al. (2005) Standardized assessment of whole body adipose tissue topography by MRI. Journal of Magnetic Resonance Imaging, 21, 455-462. (Pubitemid 40446442)
18. Pearson, T.L., (2010) Practical aspects of insulin pen devices. Journal of Diabetes Science and Technology, 4, 522-531.
19. Brambilla, P., Bedogni, G., Moreno, L.A., et al. (2006) Crossvalidation of anthropometry against magnetic resonance imaging for the assessment of visceral and subcutaneous adipose tissue in children. International Journal of Obesity, 30, 23-30. (Pubitemid 41790773)
20. Birkebaek, N.H., Solvig, J., Hansen, B., et al. (2008) A 4-mm needle reduces the risk of intramuscular injections without increasing backflow to skin surface in lean diabetic children and adults. Diabetes Care, 31, 65.
21. Strauss, K., Hannet, I., McGonigle, J., et al. (1999) Ultra-short (5mm) insulin needles: trial results and clinical recommendations. Practical Diabetes International, 16, 218-221.